Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) released earnings for its full year that Increased, from last year
The company's earnings totaled RMB173.20 million, or RMB0.43 per share. This compares with RMB33.54 million, or RMB0.08 per share, last year.
The company's revenue for the period rose 40.6% to RMB1.379 billion from RMB980.45 million last year.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB173.20 Mln. vs. RMB33.54 Mln. last year.-EPS: RMB0.43 vs. RMB0.08 last year.-Revenue: RMB1.379 Bln vs. RMB980.45 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.